Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 31

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy

Ornoy, Asher, Becker, Maria, Weinstein-Fudim, Liza, Ergaz, Zivanit · 2020 · International Journal of Molecular Sciences

Abstract

S-adenosylmethionine (SAMe) is involved in many transmethylation reactions in most living organisms and is also required in the synthesis of several substances such as monoamine neurotransmitters and the N-methyl-D-aspartate (NMDA) receptor. Due to its important role as an epigenetic modulator, we discuss in some length the process of DNA methylation and demethylation and the critical periods of epigenetic modifications in the embryo, fetus, and thereafter. We also discuss the effects of SAMe deficiency and the attempts to use SAMe for therapeutic purposes such as the treatment of major depressive disorder, Alzheimer disease, and other neuropsychiatric disorders. SAMe is an approved food additive and as such is also used during pregnancy. Yet, there seems to scanty data on the possible effects of SAMe on the developing embryo and fetus. Valproic acid (VPA) is a well-tolerated and effective antiepileptic drug that is also used as a mood stabilizer. Due to its high teratogenicity, it is contraindicated in pregnancy. A major mechanism of its action is histone deacetylase inhibition, and therefore, it acts as an epigenetic modulator, mainly on the brain. This prompted clinical trials using VPA for additional indications i.e., treating degenerative brain disease such as Alzheimer disease, dementia, HIV, and even cancer. Therefore, we discuss the possible effects of VPA and SAMe on the conceptus and early postnatally, during periods of susceptibility to epigenetic modifications. VPA is also used as an inducer of autistic-like behavior in rodents and was found by us to modify gene expression when administered during the first postnatal week but not when administered to the pregnant dams on day 12 of gestation. In contrast, SAMe modified gene expression when administered on day 12 of pregnancy but not postnatally. If administered together, VPA prevented the changes in gene expression induced by prenatal SAMe administration, and SAMe prevented the gene expression changes and autistic-like behavior induced by early postnatal VPA. It is concluded that both VPA and SAMe are powerful epigenetic modifiers with antagonistic actions on the brain that will probably be used in the future more extensively for the treatment of a variety of epigenetic diseases of the nervous system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21103721

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 115

  1. Szyf, 2015, Prospects for the development of epigenetic drugs for CNS conditions, Nat. Rev. Drug Discov., 14, 461, 10.1038/nrd4580 · DOI
  2. Finkelstein, 1990, Methionine metabolism in mammals, J. Nutr. Biochem., 1, 228, 10.1016/0955-2863(90)90070-2 · DOI · Paper page
  3. Lu, 2000, S-Adenosylmethionine, Int. J. Biochem. Cell Boil., 32, 391, 10.1016/S1357-2725(99)00139-9 · DOI · Paper page
  4. Miller, 1997, Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats, Clin. Neuropharmacol., 20, 55, 10.1097/00002826-199702000-00007 · DOI
  5. Cheng, 1997, Levels ofl-MethionineS-Adenosyltranferase Activity in Erythrocytes and Concentrations ofS-Adenosylmethionine andS-Adenosylhomocysteine in Whole Blood of Patients with Parkinson’s Disease, Exp. Neurol., 145, 580, 10.1006/exnr.1997.6466 · DOI
  6. Surtees, 1990, L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans, J. Neurol. Neurosurg. Psychiatry, 53, 569, 10.1136/jnnp.53.7.569 · DOI
  7. Mato, 1997, S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications, Pharmacol. Ther., 73, 265, 10.1016/S0163-7258(96)00197-0 · DOI · Paper page
  8. Ragnarsson, 2002, Spermine modulation of the glutamate NMDA receptor is differentially responsive to conantokins in normal and Alzheimer’s disease human cerebral cortex, J. Neurochem., 81, 765, 10.1046/j.1471-4159.2002.00872.x · DOI
  9. Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2 · DOI · Paper page
  10. Chen, 2011, DNA methylation and demethylation in mammals, J. Boil. Chem., 286, 18347, 10.1074/jbc.R110.205286 · DOI · Paper page
  11. Sharp, 2011, DNA methylation profiles of human active and inactive X chromosomes, Genome Res., 21, 1592, 10.1101/gr.112680.110 · DOI · Paper page
  12. Hanson, 2015, Developmental origins of health and disease--global public health implications, Best Pract. Res. Clin. Obstet. Gynaecol., 29, 24, 10.1016/j.bpobgyn.2014.06.007 · DOI · Paper page
  13. Kuijper, 2019, Developing differences: early-life effects and evolutionary medicine, Philos. Trans. R. Soc. B Boil. Sci., 374, 20190039, 10.1098/rstb.2019.0039 · DOI
  14. Okano, 1998, Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases, Nat. Genet., 19, 219, 10.1038/890 · DOI · Paper page
  15. Jeltsch, 2016, Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm, Nucleic Acids Res., 44, 8556, 10.1093/nar/gkw723 · DOI · Paper page
  16. Jeltsch, 2008, Reading and writing DNA methylation, Nat. Struct. Mol. Boil., 15, 1003, 10.1038/nsmb1008-1003 · DOI
  17. Cheng, 2008, Mammalian DNA Methyltransferases: A Structural Perspective, Structure, 16, 341, 10.1016/j.str.2008.01.004 · DOI · Paper page
  18. Hermann, 2004, Biochemistry and biology of mammalian DNA methyltransferases, Cell. Mol. Life Sci., 61, 2571, 10.1007/s00018-004-4201-1 · DOI · Paper page
  19. Nan, 1998, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex, Nature, 393, 386, 10.1038/30764 · DOI · Paper page
  20. Bestor, 1998, Methylation meets acetylation, Nature, 393, 311, 10.1038/30613 · DOI
  21. Kimura, 2013, Histone modifications for human epigenome analysis, J. Hum. Genet., 58, 439, 10.1038/jhg.2013.66 · DOI · Paper page
  22. Kyriakou, 2019, Histone Modifications as an Intersection Between Diet and Longevity, Front. Genet., 10, 192, 10.3389/fgene.2019.00192 · DOI
  23. Bannister, 2011, Regulation of chromatin by histone modifications, Cell Res., 21, 381, 10.1038/cr.2011.22 · DOI · Paper page
  24. Tan, 2012, Tet family proteins and 5-hydroxymethylcytosine in development and disease, Development, 139, 1895, 10.1242/dev.070771 · DOI · Paper page
  25. An, 2017, TET family dioxygenases and DNA demethylation in stem cells and cancers, Exp. Mol. Med., 49, e323, 10.1038/emm.2017.5 · DOI · Paper page
  26. Nagy, 2012, Sensitive periods in epigenetics: Bringing us closer to complex behavioral phenotypes, Epigenomics, 4, 445, 10.2217/epi.12.37 · DOI · Paper page
  27. Lee, 2014, Reprogramming the methylome: erasing memory and creating diversity, Cell Stem Cell, 14, 710, 10.1016/j.stem.2014.05.008 · DOI · Paper page
  28. Nguyen, 2007, Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan, Dev. Dyn., 236, 1663, 10.1002/dvdy.21176 · DOI · Paper page
  29. Reizel, 2018, Postnatal DNA demethylation and its role in tissue maturation, Nat. Commun., 9, 2040, 10.1038/s41467-018-04456-6 · DOI · Paper page
  30. Almstrup, 2016, Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood, Sci. Rep., 6, 28657, 10.1038/srep28657 · DOI
  31. Yuan, X., Li, Z., Ye, S., Chen, Z., Huang, S., Zhong, Y., Zhang, H., Li, J., and Zhang, Z. (2019). Genome-wide DNA methylation analysis of pituitaries during the initiation of puberty in gilts. PLoS ONE, 14. · DOI
  32. Altman, 1993, Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat, NeuroToxicology, 14, 83
  33. Rice, 2000, Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models, Environ. Health Perspect., 108, 511
  34. Semple, 2013, Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species, Prog. Neurobiol., 106, 1, 10.1016/j.pneurobio.2013.04.001 · DOI · Paper page
  35. Murphy, 2014, Oral SAMe in Persistent Treatment-Refractory Bipolar Depression, J. Clin. Psychopharmacol., 34, 413, 10.1097/JCP.0000000000000064 · DOI
  36. Wilson, 2019, S-Adenosyl Methionine (SAMe) for Depression in Adults, Issues Ment. Heal. Nurs., 40, 725, 10.1080/01612840.2017.1392161 · doi:10.1080/01612840.2017.1392161
  37. Hoffmann, A., Sportelli, V., Ziller, M., and Spengler, D. (2017). Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides. Int. J. Mol. Sci., 18. · DOI
  38. Orsolini, 2016, A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder, CNS Neurol. Disord.-Drug Targets, 15, 35, 10.2174/1871527314666150821103825 · DOI
  39. Jacobsen, 1991, Oral S-adenosylmethionine in Primary Fibromyalgia. Double-blind Clinical Evaluation, Scand. J. Rheumatol., 20, 294, 10.3109/03009749109096803 · DOI
  40. Berger, 1987, A new medical approach to the treatment of osteoarthritis. Report of an open phase IV study with ademetionine (Gumbaral), Am. J. Med., 83, 84, 10.1016/0002-9343(87)90858-8 · doi:10.1016/0002-9343(87)90858-8
  41. Friedel, 1989, S-Adenosyl-L-Methionine, Drugs, 38, 389, 10.2165/00003495-198938030-00004 · DOI · Paper page
  42. Perez, 2003, Effects of S-adenosylmethionine on hepatic regeneration after partial hepatectomy in the rat, J. Physiol. Biochem., 59, 63, 10.1007/BF03179869 · doi:10.1007/bf03179869
  43. Purohit, 2007, Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium, Am. J. Clin. Nutr., 86, 14, 10.1093/ajcn/86.1.14 · DOI · Paper page
  44. Papakostas, 2010, S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial, Am. J. Psychiatry, 167, 942, 10.1176/appi.ajp.2009.09081198 · DOI · Paper page
  45. Sarris, 2018, Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial, Eur. Neuropsychopharmacol., 28, 1126, 10.1016/j.euroneuro.2018.07.098 · DOI
  46. McCoy, 2016, Genetic predisposition to high anxiety- and depression-like behavior coincides with diminished DNA methylation in the adult rat amygdala, Behav. Brain Res., 320, 165, 10.1016/j.bbr.2016.12.008 · DOI
  47. McCoy, 2018, A paternal methyl donor depleted diet leads to increased anxiety- and depression-like behavior in adult rat offspring, Biosci. Rep., 38, 20180730, 10.1042/BSR20180730 · DOI
  48. Darby, 2016, Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders, Transl. Psychiatry, 6, e890, 10.1038/tp.2016.173 · DOI
  49. Saunderson, 2016, Stress-induced gene expression and behavior are controlled by DNA methylation and methyl donor availability in the dentate gyrus, Proc. Natl. Acad. Sci. USA, 113, 4830, 10.1073/pnas.1524857113 · DOI
  50. Song, 2005, S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor, Biochim. Biophys. Acta (BBA) Bioenergy, 1743, 205, 10.1016/j.bbamcr.2004.12.001 · DOI
  51. Gobejishvili, 2011, S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway, J. Pharmacol. Exp. Ther., 337, 433, 10.1124/jpet.110.174268 · DOI
  52. Xia, 2008, S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation, Hepatology, 47, 1655, 10.1002/hep.22231 · DOI
  53. Folstein, 2007, The homocysteine hypothesis of depression, Am. J. Psychiatry, 164, 861, 10.1176/ajp.2007.164.6.861 · DOI · Paper page
  54. Jakubowski, 2002, Homocysteine Is a Protein Amino Acid in Humans, J. Boil. Chem., 277, 30425, 10.1074/jbc.C200267200 · DOI · Paper page
  55. Škovierová, H., Vidomanová, E., Mahmood, S., Sopková, J., Drgová, A., Červeňová, T., Halasova, E., and Lehotsky, J. (2016). The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int. J. Mol. Sci., 17. · DOI · Paper page
  56. Stanger, 2009, Homocysteine, folate and vitamin B12in neuropsychiatric diseases: review and treatment recommendations, Expert Rev. Neurother., 9, 1393, 10.1586/ern.09.75 · DOI · Paper page
  57. Bottiglieri, 2000, Homocysteine, folate, methylation, and monoamine metabolism in depression, J. Neurol. Neurosurg. Psychiatry, 69, 228, 10.1136/jnnp.69.2.228 · DOI · Paper page
  58. Morris, 2003, Depression and folate status in the US Population, Psychother. Psychosom., 72, 80, 10.1159/000068692 · DOI · Paper page
  59. Hintikka, J., Tolmunen, T., Tanskanen, A., and Viinamäki, H. (2003). High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry, 3. · DOI
  60. Ornoy, 2007, Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy, Reprod. Toxicol, 24, 31, 10.1016/j.reprotox.2007.04.004 · DOI · Paper page
  61. Sarandol, 2007, Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative–antioxidative systems, Hum. Psychopharmacol. Clin. Exp., 22, 67, 10.1002/hup.829 · DOI · Paper page
  62. Sorce, 2009, NOX Enzymes in the Central Nervous System: From Signaling to Disease, Antioxid. Redox Signal., 11, 2481, 10.1089/ars.2009.2578 · DOI · Paper page
  63. Bilici, 2001, Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J. Affect. Disord., 64, 43, 10.1016/S0165-0327(00)00199-3 · DOI · Paper page
  64. Milaneschi, Y., Cesari, M., Simonsick, E.M., Vogelzangs, N., Kanaya, A.M., Yaffe, K., Patrignani, P., Metti, A., Kritchevsky, S.B., and Pahor, M. (2013). Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women. PLoS ONE, 8. · DOI
  65. Gao, 2012, Decreased NOS1 Expression in the Anterior Cingulate Cortex in Depression, Cereb. Cortex, 23, 2956, 10.1093/cercor/bhs285 · DOI
  66. Adams, 2009, The Severity of Autism Is Associated with Toxic Metal Body Burden and Red Blood Cell Glutathione Levels, J. Toxicol., 2009, 1, 10.1155/2009/532640 · DOI
  67. Huang, 2011, Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats, Neurosci. Lett., 493, 145, 10.1016/j.neulet.2011.02.030 · DOI
  68. Kulkarni, 2008, Antidepressant activity of curcumin: involvement of serotonin and dopamine system, Psychopharmacol., 201, 435, 10.1007/s00213-008-1300-y · DOI · Paper page
  69. Bouayed, 2007, Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects, J. Neurol. Sci., 262, 77, 10.1016/j.jns.2007.06.028 · DOI · Paper page
  70. Banji, 2011, Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals, Brain Res., 1410, 141, 10.1016/j.brainres.2011.06.063 · DOI
  71. Abdulla, 2013, Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro, J. Biochem. Pharmacol. Res., 1, 56
  72. Pragnya, 2014, Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice, Behav. Brain Res., 270, 86, 10.1016/j.bbr.2014.04.045 · DOI
  73. Yang, C., Bosker, F.J., Li, J., and Schoevers, R.A. (2018). N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. BMC Psychiatry, 18. · DOI
  74. Hasebe, 2017, Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor, Acta Neuropsychiatr., 29, 337, 10.1017/neu.2017.2 · DOI
  75. Cederbaum, 2010, Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury, World J. Gastroenterol., 16, 1366, 10.3748/wjg.v16.i11.1366 · DOI
  76. Lieber, 1990, S-Adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon, Hepatology, 11, 165, 10.1002/hep.1840110203 · DOI · Paper page
  77. Guo, T., Chang, L., Xiao, Y., and Liu, Q. (2015). S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis. PLoS ONE, 10. · DOI
  78. Fuso, 2012, S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice, Neurobiol. Aging, 33, 1482.e1, 10.1016/j.neurobiolaging.2011.12.013 · DOI
  79. Cavallaro, R.A., Nicolia, V., Fiorenza, M.T., Scarpa, S., and Fuso, A. (2017). S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer’s Disease Features Progression in TgCRND8 Mice. Antioxidants, 6. · DOI
  80. Li, 2017, S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-β Through Modulation of Glutathione Metabolism, J. Alzheimer’s Dis., 58, 549, 10.3233/JAD-170177 · DOI
  81. Cavallaro, 2010, S-Adenosylmethionine Prevents Oxidative Stress and Modulates Glutathione Metabolism in TgCRND8 Mice Fed a B-Vitamin Deficient Diet, J. Alzheimer’s Dis., 20, 997, 10.3233/JAD-2010-091666 · DOI
  82. Persichilli, 2015, Plasma Thiols Levels in Alzheimer’s Disease Mice under Diet-Induced Hyperhomocysteinemia: Effect of S-Adenosylmethionine and Superoxide-Dismutase Supplementation, J. Alzheimer’s Dis., 44, 1323, 10.3233/JAD-142391 · DOI
  83. Bialer, 2012, Why are antiepileptic drugs used for nonepileptic conditions?, Epilepsia, 53, 26, 10.1111/j.1528-1167.2012.03712.x · DOI · Paper page
  84. Johannessen, 2006, Valproate: Past, Present, and Future, CNS Drug Rev., 9, 199, 10.1111/j.1527-3458.2003.tb00249.x · DOI · Paper page
  85. Ghodke, 2013, Valproic acid pathway: Pharmacokinetics and pharmacodynamics, Pharmacogenet. Genom., 23, 236, 10.1097/FPC.0b013e32835ea0b2 · DOI · Paper page
  86. Zou, 2016, Upregulation of CD54 and downregulation of HLA-ABC contribute to the novel enhancement of the susceptibility of HL-60 cells to NK cell-mediated cytolysis induced by ATRA plus VPA, Oncol. Rep., 37, 105, 10.3892/or.2016.5212 · DOI
  87. Nakashima, H., Oniki, K., Nishimura, M., Ogusu, N., Shimomasuda, M., Ono, T., Matsuda, K., Yasui-Furukori, N., Nakagawa, K., and Ishitsu, T. (2015). Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. PLoS ONE, 10. · DOI
  88. Terbach, 2009, Structure–function studies for the panacea, valproic acid, Biochem. Soc. Trans., 37, 1126, 10.1042/BST0371126 · DOI
  89. Sixto-López, Y., Bello, M., and Correa-Basurto, J. (2020). Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. J. Comput. Aided Mol. Des. · DOI
  90. Chanda, 2019, Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity, Cell Stem Cell, 25, 103, 10.1016/j.stem.2019.04.021 · DOI
  91. Moldrich, 2013, Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice, Behav. Brain Res., 257, 253, 10.1016/j.bbr.2013.09.049 · DOI
  92. Qing, 2008, Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer’s disease mouse models, J. Exp. Med., 205, 2781, 10.1084/jem.20081588 · DOI · Paper page
  93. Noh, 2014, Age-dependent effects of valproic acid in Alzheimer’s disease (AD) mice are associated with nerve growth factor (NGF) regulation, Neuroscience, 266, 255, 10.1016/j.neuroscience.2014.02.012 · DOI
  94. Dedoni, 2019, Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors, J. Pharmacol. Exp. Ther., 370, 490, 10.1124/jpet.119.258129 · DOI
  95. Kavoosi, 2019, Effect of 5-aza-2’-deoxycytidine in comparison to valproic acid and trichostatin a on histone deacetylase 1, dna methyltransferase 1, and cip/kip family (p21, p27, and p57) genes expression, cell growth inhibition, and apoptosis induction in colon cancer sw480 cell line, Adv. Biomed. Res., 8, 52, 10.4103/abr.abr_91_19 · doi:10.4103/abr.abr_91_19
  96. Chen, 2017, Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1, Boil. Chem., 398, 785, 10.1515/hsz-2016-0307 · DOI
  97. Montani, 2017, Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells, Cell. Oncol., 40, 167, 10.1007/s13402-017-0314-z · DOI
  98. Crosby, 2018, Repurposing medications for use in treating HIV infection: A focus on valproic acid as a latency-reversing agent, J. Clin. Pharm. Ther., 43, 740, 10.1111/jcpt.12726 · doi:10.1111/jcpt.12726
  99. Ribalta, 1991, S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: A randomized, double-blind, placebo-controlled study with negative results, Hepatology, 13, 1084
  100. Puerta, 1998, [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats], Nutrición Hospitalaria, 13, 41
  101. Seyoum, 1994, In vitro effect of s-adenosyl methionine on ethanol embryopathy in the rat, Exp. Toxicol. Pathol., 46, 177, 10.1016/S0940-2993(11)80077-1 · DOI
  102. Yerby, 2003, Management issues for women with epilepsy: Neural tube defects and folic acid supplementation, Neurology, 61, S23, 10.1212/WNL.61.6_suppl_2.S23 · DOI
  103. Baxter, 2014, Valproate and folic acid in pregnancy: Associations with autism, Dev. Med. Child Neurol., 56, 604, 10.1111/dmcn.12498 · DOI
  104. Turgut, 2019, Valproic acid effect on neural tube defects is not prevented by concomitant folic acid supplementation: Early chick embryo model pilot study, Int. J. Dev. Neurosci., 78, 45, 10.1016/j.ijdevneu.2019.05.008 · DOI
  105. Ornoy, 2019, S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice, Neurotoxicol. Teratol., 71, 64, 10.1016/j.ntt.2018.01.005 · DOI · Paper page
  106. Weinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., and Ornoy, A. (2019). Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?. Int. J. Mol. Sci., 20. · DOI · Paper page
  107. Pillai, 2015, Association of serum VEGF levels with prefrontal cortex volume in schizophrenia, Mol. Psychiatry, 21, 686, 10.1038/mp.2015.96 · DOI
  108. Lizano, 2015, Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study, Schizophr. Res., 170, 115, 10.1016/j.schres.2015.12.001 · DOI
  109. Lee, 2009, Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis, Eur. J. Neurol., 17, 45, 10.1111/j.1468-1331.2009.02731.x · DOI
  110. Mahoney, E.R., Dumitrescu, L., Moore, A.M., Cambronero, F.E., De Jager, P.L., Koran, M.E.I., Petyuk, V.A., Robinson, R.A.S., Goyal, S., and Schneider, J.A. (2019). Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease. Mol. Psychiatry. · DOI · Paper page
  111. Udo, 2008, Enhanced Adult Neurogenesis and Angiogenesis and Altered Affective Behaviors in Mice Overexpressing Vascular Endothelial Growth Factor 120, J. Neurosci., 28, 14522, 10.1523/JNEUROSCI.3673-08.2008 · DOI
  112. Weinstein-Fudim, L., Ergaz, Z., Szyf, M., and Ornoy, A. (2020). Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA). Int. J. Mol. Sci., 21. · DOI
  113. Hollingsworth, 2008, In utero supplementation with methyl donors enhances allergic airway disease in mice, J. Clin. Investig., 118, 3462
  114. Jones, 1998, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nat. Genet., 19, 187, 10.1038/561 · DOI · Paper page
  115. Bahous, 2017, High dietary folate in pregnant mice leads to pseudo-MTHFR deficiency and altered methyl metabolism, with embryonic growth delay and short-term memory impairment in offspring, Hum. Mol. Genet., 26, 888

Cited by

See all 31

Metadata

Authors
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-05-25
Volume
21
Issue
10
Pages
3721
ISSN
1422-0067
Cited by
31
References
25
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.